BioCentury
ARTICLE | Company News

Aegis Therapeutics, Roche deal

December 7, 2009 8:00 AM UTC

Roche received non-exclusive, worldwide rights to Aegis' ProTek protein stabilization technology. ProTek uses specific excipients as protein stabilizers in manufacturing processes and is in preclinica...